These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16279807)

  • 21. Critical assessment of the automated AutoDock as a new docking tool for virtual screening.
    Park H; Lee J; Lee S
    Proteins; 2006 Nov; 65(3):549-54. PubMed ID: 16988956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination and mapping of activity-specific descriptor value ranges for the identification of active compounds.
    Eckert H; Bajorath J
    J Med Chem; 2006 Apr; 49(7):2284-93. PubMed ID: 16570925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanics methods for predicting protein-ligand binding.
    Huang N; Kalyanaraman C; Bernacki K; Jacobson MP
    Phys Chem Chem Phys; 2006 Nov; 8(44):5166-77. PubMed ID: 17203140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards an integrated description of hydrogen bonding and dehydration: decreasing false positives in virtual screening with the HYDE scoring function.
    Reulecke I; Lange G; Albrecht J; Klein R; Rarey M
    ChemMedChem; 2008 Jun; 3(6):885-97. PubMed ID: 18384086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Data mining a small molecule drug screening representative subset from NIH PubChem.
    Xie XQ; Chen JZ
    J Chem Inf Model; 2008 Mar; 48(3):465-75. PubMed ID: 18302356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PHASE: a novel approach to pharmacophore modeling and 3D database searching.
    Dixon SL; Smondyrev AM; Rao SN
    Chem Biol Drug Des; 2006 May; 67(5):370-2. PubMed ID: 16784462
    [No Abstract]   [Full Text] [Related]  

  • 27. FieldScreen: virtual screening using molecular fields. Application to the DUD data set.
    Cheeseright TJ; Mackey MD; Melville JL; Vinter JG
    J Chem Inf Model; 2008 Nov; 48(11):2108-17. PubMed ID: 18991371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of topological, shape, and docking methods in virtual screening.
    McGaughey GB; Sheridan RP; Bayly CI; Culberson JC; Kreatsoulas C; Lindsley S; Maiorov V; Truchon JF; Cornell WD
    J Chem Inf Model; 2007; 47(4):1504-19. PubMed ID: 17591764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
    Gunturi SB; Narayanan R; Khandelwal A
    Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening.
    Nagarajan S; Doddareddy Mr; Choo H; Cho YS; Oh KS; Lee BH; Pae AN
    Bioorg Med Chem; 2009 Apr; 17(7):2759-66. PubMed ID: 19285872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virtual screening of DNA minor groove binders.
    Evans DA; Neidle S
    J Med Chem; 2006 Jul; 49(14):4232-8. PubMed ID: 16821782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noise reduction method for molecular interaction energy: application to in silico drug screening and in silico target protein screening.
    Fukunishi Y; Kubota S; Nakamura H
    J Chem Inf Model; 2006; 46(5):2071-84. PubMed ID: 16995738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HAD: an automated database tool for analyzing screening hits in drug discovery.
    Shen J
    J Chem Inf Comput Sci; 2003; 43(5):1668-72. PubMed ID: 14502501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual screening for R-groups, including predicted pIC50 contributions, within large structural databases, using Topomer CoMFA.
    Cramer RD; Cruz P; Stahl G; Curtiss WC; Campbell B; Masek BB; Soltanshahi F
    J Chem Inf Model; 2008 Nov; 48(11):2180-95. PubMed ID: 18956863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based maximal affinity model predicts small-molecule druggability.
    Cheng AC; Coleman RG; Smyth KT; Cao Q; Soulard P; Caffrey DR; Salzberg AC; Huang ES
    Nat Biotechnol; 2007 Jan; 25(1):71-5. PubMed ID: 17211405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13.
    Blum LC; Reymond JL
    J Am Chem Soc; 2009 Jul; 131(25):8732-3. PubMed ID: 19505099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
    Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
    J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Learning from the data: mining of large high-throughput screening databases.
    Yan SF; King FJ; He Y; Caldwell JS; Zhou Y
    J Chem Inf Model; 2006; 46(6):2381-95. PubMed ID: 17125181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of data mining approaches to drug delivery.
    Ekins S; Shimada J; Chang C
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1409-30. PubMed ID: 17081647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supervised scoring models with docked ligand conformations for structure-based virtual screening.
    Teramoto R; Fukunishi H
    J Chem Inf Model; 2007; 47(5):1858-67. PubMed ID: 17685604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.